Many physiological, biochemical and behavioral processes operate under the circadian rhythm, which is generated by an internal timekeeping mechanism commonly referred to as the biological clock, in almost all organisms from bacteria to mammals. The core circadian oscillator is composed of an autoregulatory transcriptiontranslation feedback loop, in which CLOCK and BMAL1 are positive regulators. A cell has two mechanisms, "cell cycle" and "cell rhythm", the relationship between which remains controversial. Therefore, the aim of this study was to explore the effect of Clock and Bmal1 on cell cycle, especially on the G1 phase, using vectors with the tetracycline operatorrepressor system. The present study revealed that simultaneous induction of Bmal1 and Clock had an influential effect on the cell cycle in SW480/T -REx/Clock/Bmal1 cells, in which both Clock and Bmal1 could be induced by tetracycline. The observation that induction of both Clock and Bmal1 inhibited cell growth and the significant increase of the G1 phase proportion of in SW480/T -REx/Clock/Bmal1 cells indicated that entry from the G1 to S phase was inhibited by the induction of Clock and Bmal1. Furthermore, overexpression of Clock and Bmal1 prevented the cells from entering into the G2/M phase induced by Paclitaxel, and made the cells more resistant to the agent. In conclusion, we found that overexpression of both Clock and Bmal1 suppressed cell growth. In addition, the present study raised the possibility that Clock and Bmal1 may in part play a role in preventing the cells from entering G1 to S phase of cell cycle via suppression of CyclinD1 expression, and thus acquiring resistance to Paclitaxel.
INTRODUCTION
Circadian regulation is a regulation under which many physiological, biochemical and behavioral processes operate. It is generated by an internal timekeeping mechanism commonly known as the biological clock, and exists in almost all organisms from bacteria to mammals 1, 2) . Circadian rhythm is controlled by genetically determined networks of transcriptiontranslation feedback loops involving sets of Clock genes 3, 4) , in which Clock and Bmal1 function as positive regulators, and Period (Per) and Cryptochrome (Cry) act as negative ones 5 -7) . The basic helixloophelix -PAS domain proteins CLOCK and BMAL1 form a heterodimer, and then activate tran-scription of Per, Cry and several other genes besides clock genes through their binding to an Ebox (CAC-GTG) element at each promoter region 8, 9) . In addition, these two molecules are indispensable for maintaining the circadian rhythm feedback loop 10, 11) . After the PER and CRY proteins are translated in the cytoplasm, they form heterocomplexes and translocate into the nucleus and inhibit their own transcription 12 -14) .
In general, living cells are regulated by two different mechanisms, referred to as "circadian rhythm" and "cell cycle". Both are based on the conceptual device of interlocked autoregulatory loops. Furthermore, both are involved in therapy for patients with certain types of malignancy. "Cir-cadian rhythm" has recently been applied for chronotherapy which contributes to the reduction of side effects and enhancement of chemotherapy. Many studies have reported that the circadian clock could modulate the morbidity and the efficacy of anticancer therapy 15, 16) . These findings led to the idea of chronotherapy as a way of optimizing the efficacy of anticancer drugs for cancer patients by the modification of drug administration at appropriate times of the day. Cell cycle is one of the main targets for anticancer drugs. "A large variety of drugs have been developed and analyzed in a cell cycledependent manner 17 -19) .
Although some reports have indicated the relationship between circadian rhythm and cell cycle at the G2/M checkpoint 20, 21) , the relationship between circadian rhythm and the G1 checkpoint is still unknown. The aim of this study was to explore the effect of the simultaneous induction of both Bmal1 and Clock on the cell cycle, especially at the G1 checkpoint.
MATERIALS AND METHODS

Cells, Cell Culture and Chemicals
SW480 cells (Human colon cancer cell line)
were provided by the Institute of Development, Aging and Cancer, Tohoku University (Sendai, Japan) and cultured in RPMI 1640 (Sigma -Aldrich, St. Louis, MO, USA) containing 10% heatinactivated fetal bovine serum (FBS) 2 mM glutamine in a 5% CO 2 incubator at 37°C. Tetracycline (TET) was purchased from Invitrogen, and its stock solution was prepared in phosphate buffered saline (PBS) at a concentration of 10 mM. Dexamethasone was purchased from Sigma -Aldrich, and its stock solution was prepared in ethanol at a concentration of 2 mM. Blasticidine was purchased from Invitrogen, and its stock solutions were prepared in dimethylsulfoxide (DMSO) at a concentration of 10 mM. Paclitaxel (PTX) was purchased from Sigma, and its stock solution was prepared in DMSO at a concentration of 1 mM.
Cloning of cDNA of Clock and Bmal1, and Plasmid Construction
cDNA of human Clock and Bmal1 was amplified by PCR using human placental cDNA. The amplified human Clock and Bmal1 cDNA was then cloned into the EcoRI and NotI restriction sites of the pcD-NA4/TO vector (Invitrogen, Waltham, MA, USA), respectively. The following primer sequences were used for the cloning of the cDNA : Clock sense primer 5´-TTTAAGCTTTCCTCACAGGAGGCGT GCGG -3´ and antisense primer 5´-TTTAAGCTT TCCTCACAGGAGGCGTGCGG -3´; Bmal1 sense primer 5´-TTTGAATTCATGGCAGACCAGAGA ATGG -3´ and antisense primer 5´-TTTCTCGAG TTACAGCGGCCATGGCAAG -3´. The PCR conditions using Pyrobest polymerase (Takara Shuzo, Otsu, Shiga Prefecture, Japan) to amplify the cDNA of Clock were : 10 min at 94°C followed by 35 cycles of 30 s at 94°C, 30 s at 52°C, and 2 min at 72°C, followed by a final cycle at 72°C for 10 min. For amplification of Bmal1 cDNA, the PCR cycling parameters were the same as above, except for the use of LA Taq polymerase (Takara Shuzo) pcDNA4/TO. GFP. Bmal1 and pcDNA4/TO. RFP.Clock were generated by PCR amplification with primers containing inframe BamHI and EcoRI site, and cloning into identically digested pcDNA4/TO. Bmal1 and pcDNA 4/TO.Clock.
Establishment of Stable Bmal1/ Clock Transfected Cell Lines
pcDNA6/TR vectors (Invitrogen) were transfected into SW480 cells using Lipofectamine -Plus reagent (Invitrogen) according to the manufacturer's instructions. SW480 -pcDNA6/TR cells were selected by 100 µM of Blasticidine (Invitrogen). pcD-NA4/TO.RFP.Clock and pcDNA4/TO.GFP.Bmal1 were transfected into SW480 -pcDNA6/TR using Lipofectamine -Plus reagent (Invitrogen) according to the manufacturer's protocols, and Zeocine (100 µM)resistant clones were isolated using standard procedures. The pcDNA4/ TO.RFP.Clock and pcDNA4/ TO.GFP.Bmal1 cotransfected cells were isolated and examined by fluorescent imaging using an OLYMPUS IX81 microscope with a GFP/Rhodamine filter set (IX2 -RFAL and IX2 -RFACA, OLYMPUS, Tokyo, Japan) after treatment of the cells with 30 µg/ ml TET for 0 -48 h. The stable transfected cell line was established after three rounds of subcloning. This cell line was defined as SW480/T -REx/Clock/ Bmal1.
Production of Circadian Rhythm by Treatment with Dexamethasone
The method for induction of the circadian rhythm by treatment with dexamethasone was previously described 22) . SW480 cells were treated with 100 nM dexamethasone for 2 h, and then the medium was replaced with growth medium. CLOCK & BMAL1 CO -OVEREXPRESSION IN SW480CELLS
Conventional RT -PCR
Total RNA was extracted using TRIzol (Invitrogen) from cells, and cDNA was synthesized with 2 µg of total RNA and random hexadeoxynucleotide primer (Invitrogen) in 20 µl of a solution containing reverse transcriptase. After synthesis, the cDNA was diluted 1 : 4 with distilled water and stored at −20°C until use. Each PCR was performed with cDNA derived from 20 ng of RNA. PCR reactions were carried out in a total volume of 20 µl containing cDNA, dGTP, dATP, dTTP, and dCTP at a concentration of 200 µM, 4 µM of each primer and 0.25 units of ExTaq polymerase (Takara Shuzo). The PCR primer used in this study is listed in Table 1 . The PCR cycling parameters were as follows : 10 min at 94°C followed by 35 cycles of 30 s at 94°C, 30 s at 55°C, and 2 min at 72°C, followed by a final extension at 72°C for 10 min. The PCR products were electrophoresed on a 2% agarose gel.
Quantitative Real -Time RT -PCR
For quantification, cDNA was used as a template in a realtime RT -PCR assay (Bio -Rad Laboratories, Hercules, CA, USA), according to the manufacturer's protocol. G3PDH served as an internal control and was amplified parallel with every sample. The oligonucleotide primers for the detection of every gene expression and the G3PDH gene are listed in Table 1 . The constituents of each PCR (15 µl) were 1 µl of cDNA, 1.0 µl of primer 15 pmol/liter each, 5.5 µl of distilled H 2 O, and 7.5 µl of iQ SYBR Green Supermix (Bio -Rad Laboratories).
Cell Count Assay
SW480 and SW480/T -REx/Clock/Bmal1 cells were plated at a density of 3.0 × 10 4 /25 cm 2 . When the cells were attached to the bottom of the flask, the medium was changed to growth medium with 30 mg/ml TET. After 48 h, the cells were harvested and counted every 24 h.
Flow Cytometry
Samples were prepared for flow cytometry. Briefly, cells were harvested, washed in icecold PBS (pH 7.4), fixed in icecold 70% ethanol, and treated with RNase (500 units/ml ; Invitrogen) at 37°C for 20 min. Cellular DNA was stained with 50 µg/ml of propidium iodide (Sigma Chemical Co., St. Louis, MO, USA), and cells were stored at 4°C. Cell cycle analyses were performed using a Becton Dickinson fluorescenceactivated cell analyzer (Becton Dickinson, Mansfield, MA, USA). Cells (1 × 10 4 ) were analyzed for each point, and quantization of cell cycle distribution was performed using Modfit LT (Verity Software House, Topsham, ME, USA). All experiments were performed when cells reached 50% confluence. 
Immunoblotting
Cells were lysed with icecold RIPA lysis buffer (150 ng NaCl, 5 mM Tris -HCl at pH 7.2, 1% Nonidet P -40, 1% sodiumdeoxycorate, 0.05% Sodium dodecyl sulfate) and a protease inhibitor cocktail (Sigma -Aldrich). Protein concentrations were adjusted by the cell number, 2.60 × 10 6 cells/1 ml RIPA buffer. Proteins were separated in 8% SDS -PAGE and transferred to PVDF membrane (Bio -Rad Laboratories). The transferred proteins were reacted with anti -RFP polyclonal antibody (Medical & Biological Laboratories CO, Nagoya, Japan), anti -GFP Nterminal developed in rabbit affinity isolated antibody (Sigma -Aldrich), and alphatublin (Sigma -Aldrich) at 4°C over night, followed by incubation for 30 min at room temperature with horseradish peroxidaseconjugated goat antirabbit IgG (Vector Laboratories, Burlingame, CA, USA) or horseradish peroxidaseconjugated goat antimouse IgG (Vector Laboratories). Antibody binding was visualized with the ECL system (GE Healthcare, Little Chalfont, Buckinghamshire, UK).
Immunoprecipitation
The cells were washed with icecold PBS, and the cytosol was lysed with buffer A (10 mM HEPES [pH 7.9], 1.5 mM MgCl 2 , 0.5 mM DTT) with proteinase inhibitor cocktail (Sigma -Aldrich). Deposits were lysed with buffer C (20 mM HEPES [pH 7.9], 20% (v/v) glycerol, 0.6 M KCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT) with proteinase inhibitor cocktail (Sigma -Aldrich). The supernatants were diluted using distilled water and transferred to a fresh tube, and 2.5 µg of anti -GFP antibody (Sigma -Aldrich) or nonspecific rabbit IgG was added, followed by incubation at 4°C for 1.5 h. Then, 30 µl of Protein G Sepharose (GE healthcare) was added and the mixture was incubated at 4°C for 1.5 h. The supernatants were discarded carefully, 1X sodium dodecyl sulfate sample buffer was added, and the samples were boiled for 5 min. They were then separated in 8% SDS -PAGE and transferred to a PVDF membrane (Bio -Rad Laboratories). Immunoblotting was performed with Anti -RFP antibody (Medical & Biological Laboratories CO) or anti -GFP antibody (Sigma -Aldrich) as a primary antibody, and horseradish peroxidaseconjugated antirabbit antibody as a secondary antibody. Antibody binding was visualized with the ECL system (GE Healthcare).
MTT Assays
The cytotoxicity of the anticancer drugs was measured using the MTT colorimetric assay (Sigma Chemical Co.). The cells were seeded in a 96 -well plate with growth medium. On the following day, the medium was changed to 180 µl of RPMI 1640 containing 10% FBS and 30 µg/ml of TET. Thereafter, 20 μl of PTX at each concentration (30 nM -30 µM) was added to the wells (the final concentrations were 3 nM -3 µM) and incubations were continued at 37°C for four days, after which 50 µl of MTT (1 mg/ ml PBS) was added to each well. After 4 h additional incubation at 37°C, the resulting formazan was dissolved in 90 µl of DMSO. Optical densities were read immediately at 570 nm by using a Micro Plate Reader (Bio -Rad Laboratories).
RESULTS
Induction of Circadian Rhythm in Human Colon Cancer Cell Line, SW480
We investigated whether SW480 cells show rhythm under dexamethasone treatment as described in the Materials and Methods section. The mRNA expression of circadian rhythmrelated genes including Clock, Bmal1, Per1, Per2, Per3, Cry1, and Cry2 was examined by conventional RT -PCR (Fig. 1A) . The mRNA levels of almost all genes were changed depending on time after treatment. We further performed realtime RT -PCR using the same samples (Fig. 1B) . The mRNA levels of Bmal1, Per1, and Cry1 were changed periodically, while Clock expression was not changed significantly. Per1 mRNA expression seemed to be inversely correlated with Bmal1 mRNA level.
Establishment of Both Clock and Bmal1 Stably Transfected Cell Lines
To observe the effects of Clock and Bmal1 on the cell cycle, vectors including Clock or Bmal1, in which TET regulated the target gene expressions, were constructed as described in the Materials and Methods section. The expression of both Clock and Bmal1 at the time after treatment with 30 μg/ml TET in the SW480/T -REx/Clock/Bmal1 cells, was examined by conventional RT -PCR ( Fig. 2A ), realtime PCR (Fig. 2B) , fluorescence microscopy and immunoblotting ( Figs. 2C and 2D ). The CLOCK/ BMAL1 heterodimer activates transcription of Per1 through binding to an Ebox element in the Per1 promoter region 9) ; therefore, Per1 expression was CLOCK & BMAL1 CO -OVEREXPRESSION IN SW480CELLS used as a positive control in Figs. 2A and 2B . Both Clock and Bmal1 expression levels were increased in a timedependent manner with an increase of Per1 after TET treatment in SW480/T -REx/Clock/Bmal1 cells. Immunoprecipitation showed a CLOCK and BMAL1 -formed heterodimer in our new cell line as already described 8, 9) (Fig. 2E ).
Overexpression of Both Clock and Bmal1 Suppressed Cell Growth
After establishment of the SW480/T -REx/ Clock/Bmal1 cells, we performed a cell count assay (Fig. 3) . Cell growth was remarkably suppressed by both Clock and Bmal1 induction. At 72 h, the growth ratio of the SW480/T -REx/Clock/Bmal1 cells was significantly less than that of the SW480 cells (5.32 ± 0.82 vs 2.57 ± 0.49, p=0.038).
Effect of Both Bamal1 and Clock Induction on Cell Cycle
To determine how the induction of these two (Fig. 4A) . The proportion of G1 phase with and without TET treatment in both cell lines was plotted (Fig. 4B) . The proportion of the cells in G1 -phase in the SW480/T -REx/Clock/Bmal1 cells (68.40 ± 0.84 % at 24 h, 73.15 ± 1.62% at 48 h) was significantly higher than that in the SW480 cells (63.59 ± 0.49% at 24 h, 58.73 ± 1.19% at 48 h) (p=0.028 at 24 h, p=0.001 at 48 h) ( Fig. 4B) . To demonstrate increased G1 proportion by Clock and Bmal1 induction more clearly, we performed flow cytometry with cell cycle synchronization by serum starvation (Supplementary Fig. 1 ). These data indicated that overexpression of both Clock and Bmal1 had an inhibitory effect on entry to the S phase.
Overexpression of Clock and Bmal1 Suppressed Cy-clinD1 Expression
To investigate how overexpression of Clock and Bmal1 inhibits entry to the S phase, we examined CyclinD1 expression level by realtime RT -PCR ( Fig. 5 ). Before TET treatment, the CyclinD1 expression level of the SW480/ T -REx/Clock/Bmal1 cells was the same as that of the SW480 cells (1.0 ± 0.14 vs 1.06 ± 0.13, N.S.), but after TET treatment, the CyclinD1 expression level of the SW480/T -REx/ Clock/Bmal1 cells was decreased in comparison with that of the SW480 cells in a timedependent manner. At 48 h after TET treatment, the CyclinD1 expression level of the SW480/T -REx/Clock/Bmal1 cells was significantly decreased (0.70 ± 0.05 vs 0.38 ± 0.03, p=0.0048). These data suggested that both Clock and Bmal1 overexpression might suppress Cy-clinD1 expression directly or indirectly, and that entry to the S phase was inhibited due to the decrease of CyclinD1 expression.
Overexpression of Both Clock and Bmal1 Change the Sensitivity to PTX
PTX, a clinically active anticancer agent isolated from the bark of the Pacific yew tree, inhibits mitotic spindle assembly or function, and the progression of mitotic cells to the G1 phase 18) . If overexpression of both Clock and Bmal1 has an inhibitory effect on entry to the S phase, the effect could compete for the pharmacological mechanism of PTX. We examined whether induction of these two genes altered the sensitivity to PTX. Without TET treat- ment, PTX inhibited cell cycle progression in the G2/M phase of both the SW480 and SW480/T -REx/ Clock/Bmal1 cells equally. However, 24 h following TET treatment, the proportion of the G2/M phase in the SW480/T -REx/Clock/Bmal1 cells was signifi-cantly lower than that in the SW480 cells (46.22 ± 1.09% vs 33.66 ± 1.63%, p=0.0127) (Figs. 6A and  B ). Furthermore, MTT assay showed that the induction of these two genes made the SW480 cells resistant to PTX (Fig. 7) . Although TET itself has an effect on the cell cycle to arrest at the G1 phase, the present data showed that simultaneous induction of Clock and Bmal1 changes the chemosensitivity to PTX by inhibiting entry to the G2/M phase in SW480/T -REx/Clock/Bmal1 cells.
DISCUSSION
We confirmed that Clock and Bmal1 form a heterodimer and promote Per1 expression using SW480/T -REx/Clock/Bmal1 cells. It is important to note "both Clock and Bmal1" not "either Clock or Bmal1", because the two proteins form a heterodimer, and bind to an Ebox element at the promoter region of the target genes 9) . We showed that CLOCK and BMAL1 made a complex by immunoprecipitation. Kwon et al. reported that singly expressed CLOCK proteins were located in the cytoplasm but when CLOCK and BMAL1 were coexpressed they were found in the nucleus 23 ; thus, Fig. 2C indicates that CLOCK and BMAL1 were dimerized in our cell line. One of the advantages of using the T -REx TM system is the gradual induction of the target genes in a timedependent manner ; we can observe the change that the genes cause more precisely by chasing the time course.
The major findings of the present study were as follows ; i) overexpression of both Clock and Bmal1 simultaneously inhibited cell growth, ii) the mechanism of slow cell growth was an inhibitory effect of these two genes on entry from the G1 phase to the S phase at cell cycle level, iii) in the Clock and Bmal1 overexpressed cells, CyclinD1 was downregulated, which may be a cause of increased G1 proportion, iv) overexpression of both Clock and Bmal1 made cells more resistant to PTX.
We demonstrated that the simultaneous overexpression of both Clock and Bmal1 inhibited cell growth possibly by inhibiting entry from the G1 phase to the S phase at the cell cycle level. To the best of our knowledge, this is the first report to indicate that Clock and Bmal1 are involved in cell growth. Although Gorvacheva et al. have already produced Clock mutant/Bmal1 knockout mice, they did not report any growth abnormalities of the mice 16) . Matsuo et al. reported that liver regeneration of Cry1 −/− and Cry2 −/− mice is slower than that of wild type mice 20) . In comparison with these reports, our data is not necessarily contradictable, because in Cry1 −/− and Cry2 −/− mice, Clock and Bmal1 expression levels should be relatively higher than those in wild type mice. In addition, it has been already reported that circadian clock genes Per1 and Per2 are involved in the G2/M or ATM checkpoints of the cell cycle 20, 21) , but there is yet to be report showing that the circadian gene is directly involved in the G1 checkpoint.
Gery et al. showed that PER1 interacted with Chk2, a key kinase of the ATM checkpoint pathway, and the expression levels of Wee1 and CyclinB1, key molecules for the entry from the G2 phase to the M phase, were downregulated by overexpression of Supplemental figure. SW480 cells and SW480/T -REx/Clock/Bmal1 cells were plated at a density of 1.0 × 10 6 /75 cm 2 . After 48 h, the medium was changed to RPMI 1640 medium supplemented 0.2% FBS and 30 μg/ml TET. Then, 48 h after the medium change, the medium changed to a growth mediumsupplemented 30 μg/ml TET. The samples were harvested and fixed for flow cytometry every 24 h as described above. Each bar represents the mean ± SD (bars) of three independent experiments. The proportion of G1 phase was plotted in a graph. Statistical differences were calculated by using Student's ttest. These data strongly suggest that overexpression of both Clock and Bmal1 had an inhibitory effect on entry to the S phase. CLOCK & BMAL1 CO -OVEREXPRESSION IN SW480CELLS region, and CLOCK and BMAl1 together produced a major increase in transcriptional activity of Wee1 20) . These reports were referred to G2/M checkpoint molecules. The G1 checkpoint is thought to be the most major checkpoint of the cell cycle, and CyclinD is the first response gene that connects growth signal and the start of the cell cycle. The expression of CyclinD1 has reportedly been involved in the circadian system in vitro and in animal models 24 -27) ; however, these reports simply showed that expression of CyclinD1 had a circadian rhythm, and did not show that it detailed control mechanisms. Our data suggested that CyclinD1 might be suppressed by the Clock -Bmal1 heterodimer or by other genes activated by the one. Of importance is the fact that the characteristics of the SW480/T -REx/Clock/Bmal1 cells in the present study that should be mentioned are "gradual induction" and "not so much overexpressed Clock and Bmal1". In this cell line, Clock and Bmal1 were gradually induced over a period of 24 h, and peak expression levels were about seven times (Clock) and 15 times (Bmal1) of the unsynchronized SW480 expression levels. Therefore, it was not so unnatural that Clock and Bmal1 expression levels were about 10 times those of unsynchronized SW480, in comparison that Bmal1 expression level of synchronized SW480 changed between 1 to 2.5 times (Fig. 1B) . Several reports suggest that mouse circadian rhythm, CLOCK and BMAL1 abundance are relatively higher at night 25, 28, 29) . The results of the present study may indicate possibility that the administration of PTX at night is not as effective as its daytime administration. To confirm this hypothesis, further studies are required.
In conclusion, our present data raised the possibility that Clock and Bmal1 may have an effect on the G1 checkpoint of the cell cycle either directly or indirectly, and may change the sensitivity to PTX l of the human colon carcinoma cell SW480.
